In cases such as breast and ovarian cancer, the detection of BRCA1 and BRCA2 mutations facilitates targeted interventions, including chemoprevention and risk-reducing surgeries, which have proven efficacy in lowering the incidence of cancer in high-risk populations [2, 109, 110]. This evidence concerns the gene BRCA1 and ovarian carcinoma.